The wearable cardiac monitor and defibrillator developer Kestra Medical Technologies aims to raise about $154 million by ...
Discover key insights from Lineage Inc.'s Q4 2024 earnings call, including innovation milestones, strong AFFO growth, and a transformative outlook for 2025.
International Gemmological Institute India Ltd (IGIL), a newly-listed company, is set to pay an interim dividend to its ...
NSDL, India’s largest depository, is launching a ₹3,000 crore IPO in March, entirely as an offer for sale. Key banking stocks ...
7h
Hosted on MSNAzad Engineering launches Rs 700 crore QIP: All you need to knowThe company's board approved the opening of the issue on February 25 for the QIP of equity shares with a face value of Rs 2 ...
8h
Hosted on MSNSTAK Inc Announces Pricing of Initial Public OfferingSTAK Inc. (the "Company" or "STAK"), a fast-growing company specializing in the research, development, manufacturing, and sale of oilfield-specialized production and maintenance equipment, today ...
Metsera's IPO raised $316.2 million, funding its obesity drug MET-097i, which shows promise with once-monthly dosing. Read ...
Mirae Asset Mutual Fund has launched four new investment schemes, catering to two distinct themes—Initial Public Offerings ...
CTRL GROUP’s (NASDAQ:MCTR – Get Free Report) quiet period is set to expire on Monday, March 3rd. CTRL GROUP had issued 2,000,000 shares in its IPO on January 22nd. The total size of the offering was ...
18h
Hosted on MSNHow To Invest in the ThoughtSpot IPO: A Beginner’s GuideInvesting in ThoughtSpot’s IPO might be a good move to add to your portfolio, It has beating out competitors other analytics ...
Guggenheim has initiated coverage of Metsera (NASDAQ:MTSR) with a buy rating, citing the company's obesity drug candidates.
Australia's securities regulator has urged the nation's stock exchange operator to be more proactive in making it easier and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results